Evaluation of the association of Bartonella species,feline herpesvirus 1,feline calicivirus,feline leukemia virus and feline immunodeficiency virus with chronic feline gingivostomatitis

Abstract

Gingivostomatitis (GS) is a significant condition in cats because of oral discomfort and associated periodontal disease. Several infectious agents have been associated with the presence of GS, but a causal relationship is unclear. The cats in this study were housed together, had a history of flea exposure, and were vaccinated with a modified live FVRCP product. There were nine cats with active GS and 36 unaffected cats at the time of sample collection. Serum was tested for feline leukemia virus (FeLV) antigen and antibodies against feline immunodeficiency virus, feline calicivirus (FCV), feline herpesvirus 1 (FHV-1), and Bartonella species (enzyme-linked immunosorbent assay and Western blot immunoassay). PCR assays for Bartonella species and FHV-1 and a reverse transcriptase PCR assay for FCV were performed on blood and throat swabs. All cats were negative for FeLV. Assay results failed to correlate to the presence of GS in the group of cats studied.

Gingivostomatitis (GS) is often recognized in feline patients and is clinically characterized by erythematous and swollen gums, halitosis and the potential for significant oral discomfort resulting in dysphagia, anorexia, and weight loss. In addition to being painful to the animal, the chronic inflammation of the gingiva can lead to progressive periodontal disease (Lyon 2005). The diagnosis is based on histopathology and characterization of reactive cells in the tissue, which most frequently consists of infiltrations of plasma cells primarily, with lesser numbers of lymphocytes, neutrophils, and macrophages (Lyon 2005). The syndrome is likely to be multifactorial and it is theorized to involve an exaggerated immune response to either infectious or non-infectious antigens. Genetic predisposition, nutritional factors, environment stresses, and domestication have also been proposed as playing a part in the syndrome (Lyon 2005).

Infectious agents suspected to be associated with GS in cats include feline immunodeficiency virus (FIV) (Knowles et al 1989, Tenorio et al 1991, Waters et al 1993), feline leukemia virus (FeLV) (Knowles et al 1989, Tenorio et al 1991), feline calicivirus (FCV) (Knowles et al 1989, 1991, Tenorio et al 1991, Waters et al 1993, Addie et al 2003, Lommer and Verstraete 2003), feline herpesvirus 1 (FHV-1) (Hargis and Ginn 1999, Lommer and Verstraete 2003), Bartonella species (Ueno et al 1996, Glaus et al 1997, Dowers and Lappin 2005), and a variety of other bacteria. However, all of these agents can be harbored by both healthy and clinically ill cats, so a causal relationship is difficult to prove in individual cats. It is also difficult to compare the results of previous studies because the agents tested for varied amongst the studies and the diagnostic methods were not standardized. Further information concerning the role infectious agents play in this syndrome is needed to help design improved diagnostic and therapeutic plans. The purpose of this study was to perform a standardized infectious disease diagnostic workup in a group of communally housed, mixed source, client-owned cats with and without GS in an attempt to determine infectious disease associations and to determine the optimal diagnostic workup.

Materials and methods

Feline colony

The cats in this study were in southern California and had been allowed to commingle for 3–15 years (mean = 8.2 years). The cats were owned by a veterinary technician that acquired them from a shelter (nine cats), as strays (nine cats), by capture (13 cats; considered feral), and from previous owners (eight cats). All of the cats had a history of exposure to fleas 1.5 years previously, but had no evidence of current infestation. Each of the cats had been vaccinated previously with a FHV-1, FCV, and panleukopenia containing vaccine (Feline UltraNasal FVRCP Vaccine; Heska Corporation, Loveland, Colorado) approximately 1 year prior to sample collection in this study. None of the cats were administered antimicrobial drugs within the 2 weeks before sampling.

Sample handling

At the time of sample collection, it was determined by one of the authors (TE) whether the cats were unaffected or currently had GS. GS was determined by presence of significant swollen, erythematous oral lesions including gingivitis, faucitis and stomatitis. Cats that were determined to be unaffected had no significant erythematous oral lesions. Blood (3 ml) was collected and placed into an EDTA tube (1.5 ml draw) and a clot tube for serum separation. A dry cotton swab was rolled over the lesion (GS cats) or caudal pharynx (normal cats) and was then placed in 1.0 ml of sterile 0.01 M phosphate buffered saline and allowed to equilibrate at room temperature for 2–3 h. The EDTA tube, serum, and swabs were then stored at −20°C until shipped to Colorado State University by overnight express on dry ice where they were stored at −70°C until assayed.

Assays

Serum was tested for FeLV antigen (SNAP Combo FeLV/FIV; Idexx Laboratories, Portland, ME) and antibodies against FIV (SNAP Combo FeLV/FIV; Idexx Laboratories, Portland, ME), FCV (Lappin et al 2002), FHV-1 (Lappin et al 2002), and Bartonella species (Lappin et al., 2006a). Bartonella species antibody responses were determined by both enzyme-linked immunosorbent assay (ELISA) and Western blot immunoassay.

After thawing the samples at room temperature, DNA and RNA were extracted from blood and swabs using a commercially available kit (Qiagen, Valencia, CA) according to the manufacturer's protocol. For swabs, 50 μg salmon sperm DNA (Invitrogen Corporation, Carlsbad, CA) was added per milliliter of manufacturer's lysis buffer. The swab was pressed against the side of the tube to expel all possible liquid and discarded. The entire sample was vortexed, transferred to a 1.5 ml of RNase and DNase free microcentrifuge tube and centrifuged for 5 min at 500 × g. Supernatant was decanted and the remaining pellet was resuspended in 400 μl of sterile 0.01 M PBS. The remainder of the manufacturer's protocol was followed as written. Each DNA extract was assessed for the presence of DNA by spectrophotometry. PCR assays used to amplify DNA of Bartonella species (Jensen et al 2000) and FHV-1 (Burgesser et al 1999) were performed as previously described on all DNA extracts. A reverse-transcription PCR (RT-PCR) assay used to amplify RNA of FCV was performed as previously described on all RNA extracts (Sykes et al 1998).

Statistical evaluation

To assess for associations between Bartonella species, FHV-1 and FCV and GS, numbers of positive test results in cats with and without GS were compared by two-tailed Fisher's exact test with significance defined as P < 0.05. To determine if any of the test results could be used to predict GS in cats, positive predictive value and negative predictive value (PPV and NPV) were determined for each assay by comparing to the current presence or absence of GS.

Because it is unknown whether the Bartonella species ELISA or Western blot immunoassay is the gold standard, sensitivity and specificity between the two assays could not be calculated. Thus, results of the ELISA and Western blot (WB) immunoassay were compared by calculating percentage agreement using the following formula.

\begin{array}{l} [(ELISA +, WB +) + (ELISA -, WB -)] / \\ \times [(ELISA +, WB +) + (ELISA -, WB -) \\ + (ELISA +, WB -) + (ELISA -, WB +)] \\ \times 100 \end{array}

To determine whether Bartonella species antibodies detected by ELISA or Western blot (WB) correlated to the presence or absence of bacteremia, the PPV and NPV of the antibody tests were calculated using blood PCR results as a gold standard.

Results

Overall, samples were available from 45 cats; 36 unaffected cats and nine with GS. Of the unaffected cats, estimated ages were <1 year (zero cats), 1–3 years (zero cats), 4–6 years (six cats), 7–9 years (10 cats), 10–12 years (11 cats), >13 years (seven cats) and the age was unknown for two cats. Of the cats without GS, estimated ages were <1 year (zero cats), 1–3 years (zero cats), 4–6 years (one cat), 7–9 years (four cats), 10–12 years (four cats), >13 years (zero cats) and the age was unknown for zero cats. Seventeen males and 19 females were clinically unaffected and five males and four females exhibited GS. All of the cats were negative for FeLV antigen. Five cats were positive for FIV antibodies. Overall, prevalence rates for Bartonella species antibodies by ELISA, Bartonella species antibodies by Western blot, FHV-1 antibodies, FCV antibodies, and FIV antibodies were 44%, 57.8%, 95.6%, 100%, and 10.9%, respectively. The distribution of the serological test between groups is presented in Table 1. None of the positive test results was associated with the presence of GS. However, Bartonella species Western blot results were negatively associated with GS (P = 0.0243; odds ratio = 0.1429). None of the PPVs of the serological tests was >40% (Table 2).

Table 1

Distribution of serum antibody test results in group housed cats with (n = 9) and without (n = 36) stomatitis

Group	Bartonella ELISA		Bartonella Western blot		FHV-1 ELISA		FCV ELISA		FIV ELISA
	Pos	Neg	Pos	Neg	Pos	Neg	Pos	Neg	Pos	Neg
Stomatitis	4 (44.4%)	5 (55.6%)	2 (22.2%)	7 (77.8%)	9 (100%)	0 (0%)	9 (100%)	0 (0%)	2 (22.2%)	7 (77.8%)
Unaffected	16(44.4%)	20 (55.6%)	24 (66.7%)	12 (33.3%)	34 (94.4%)	2 (5.6%)	36 (100%)	0 (0%)	3 (8.3%)	33 (91.7%)
Fisher's^a	P = 1		P = 0.0243		P = 1		P = 1		P = 0.258

Two-tailed Fisher's exact test; Pos = positive; Neg = negative.

Table 2

Predictive values of Bartonella species, FHV-1, FCV and FIV antibody tests for use with cats with stomatitis

	Bartonella ELISA	Bartonella Western blot	FHV-1 ELISA	FCV ELISA	FIV ELISA
PPV (%)	20.0	7.7	20.9	20.0	40
NPV (%)	80	63.2	100	0	82.5

PPV = positive predictive value; NPV = negative predictive value

When the ELISA and Western blot immunoassay tests were compared, a 60% percentage agreement was found. The discordant results were ELISA positive, Western blot negative (n = 6) and ELISA negative, Western blot positive (n = 12). Overall, 26 cats were Western blot positive (two cats had GS) and numbers of Bartonella species immunodominant antigens recognized ranged from two to eight antigens per cat. The most commonly recognized antigens had apparent molecular masses of 82 kDa (19 cats), 61.9 kDa (14 cats); 48 kDa (13 cats), and 57 kDa (11 cats).

Overall, prevalence rates for Bartonella species DNA in blood, Bartonella species DNA on oral swabs, FHV-1 DNA on oral swabs, and FCV RNA on oral swabs were 2.2%, 11.1%, 6.7%, and 6.7%, respectively. The distribution of PCR and RT-PCR test results between groups is presented in Table 3. None of the positive test results was associated with the presence of GS. The PPVs for Bartonella species DNA, FHV-1 DNA, and FCV RNA on oral swabs were 20%, 0%, and 0%, respectively (Table 4). While the PPV of the Bartonella species DNA in blood was 100%, only one positive sample was detected. Of the five cats with Bartonella species DNA amplified from oral swabs, only one had GS and none had Bartonella species DNA amplified from blood.

Table 3

Distribution of PCR and RT-PCR assay results in group-housed cats with (n = 9) and without (n = 36) stomatitis

Group	Bartonella PCR-blood		Bartonella PCR-swab		FHV-1 PCR-swab		FCV RT-PCR
	Pos	Neg	Pos	Neg	Pos	Neg	Pos	Neg
Stomatitis	1 (11.1%)	8 (89.9%)	1 (11.1%)	8 (89.9%)	0 (0%)	9 (100%)	0	9 (100%)
Unaffected	0 (0%)	36 (100%)	4 (11.1%)	32 (89.9%)	3 (8.3%)	33 (91.7%)	3 (8.3%)	33 (91.7%)
Fisher's^a	P = 0.2		P = 1		P = 1		P = 1

Two-tailed Fisher's exact test; Pos = positive; Neg = negative.

Table 4

PPV and NPV for PCR tests for use with cats with stomatitis

	Bartonella PCR-blood	Bartonella PCR-swab	FHV-1 PCR-swab	FCV RT-PCR
PPV (%)	100	20.0	0	0
NPV (%)	81.8	80.0	78.6	78.6

Positive Bartonella species culture or PCR assay on blood can be used to determine bacteremia. When compared to Bartonella species PCR assay results from blood, the PPV and NPV of the Bartonella species ELISA results for predicting bacteremia were 0% and 96%, respectively. When compared to Bartonella species PCR assay results from blood, the PPV and NPV of the Bartonella species WB results for predicting bacteremia were 0% and 95%, respectively.

Discussion

Bartonella species, FHV-1, FCV, FeLV, and FIV can be carried chronically by cats and have been proposed as causes of GS. The cats in this study were housed together, were vaccinated with a modified live FVRCP vaccine intranasally, and had a history of exposure to fleas. This history combined with the serologic test results and PCR assay results suggest that each of the cats had been exposed to at least one of these agents. However, evidence of infection with Bartonella species, FHV-1, FCV, FeLV or FIV was not overrepresented in the cats with GS and so the data fail to support the hypotheses that these organisms were a cause of GS in this population of cats. However, there are a number of factors or limitations that may have influenced the results of this study including sampling, shipping and storage factors, clearance or latency of the organisms, presence of subsets of GS, and potential variations in organism virulence.

Results of this study support previous research in the literature which asserts that because of the high prevalence rates of Bartonella species antibodies in normal cats from natural exposure, a positive antibody assay cannot be used to accurately predict clinical illness from this agent in individual cats (Breitschwerdt et al 2005, Pearce et al 2006). In an attempt to further evaluate clinical utility of antibody assay results, antigen recognition patterns were examined by Western blot. Bartonella species antigen recognition patterns in the two cats in this study with GS were similar to those of normal cats and so the Western blot immunoassay did not appear to provide additional predictive value. These results are similar to another study on cats with and without fever (Lappin et al., 2006a). Finally, the results of this study are also similar to those of others that show that detection of Bartonella species antibodies by any methodology does not accurately predict presence of Bartonella species bacteremia (Chomel et al 1995, Fabbi et al 2004, Guptill et al 2004, Lappin et al., 2006a).

While most cats with experimental Bartonella species infection have been clinically normal, fever, loss of appetite, transient anemia, injection site reactions, lymphadenopathy, and neurological signs have been detected in some cats (Regnery et al 1996, Abbot et al 1997, Guptill et al 1997, Kordick and Breitschwerdt 1997, Guptill et al 1998, 1999, Kordick et al 1999, O'Reilly et al 1999, Mikolajczyk and O'Reilly 2000, Powell et al 2002, Yamamoto et al 2002a, 2002b, 2003). In addition, some experimentally inoculated cats develop histopathological lesions including lymph node hyperplasia, abscesses, and lymphocytic inflammation of various tissues (Guptill et al 1997, Kordick et al 1999). However, no mention of gingival abnormalities was made in these studies. Bartonella species infection of naturally exposed cats has been associated with endocarditis (Chomel et al 2003) and ocular disease (Lappin and Black 1999, Lappin et al 2000, Ketring et al 2004). To date, the only studies suggesting that Bartonella species infection causes GS in cats were small serological studies from Europe and Japan (Ueno et al 1996, Glaus et al 1997). However, another ongoing study comparing results of Bartonella species PCR on blood and serum Bartonella species IgG ELISA results on cats with and without GS from which samples were collected the same day in the same clinic has also failed to show an association between Bartonella species and GS (Dowers and Lappin 2005).

The widespread use of FHV-1 and FCV containing vaccines and exposure to these common feline viruses has resulted in high prevalence rates of FHV-1 (Maggs et al 1999) and FCV (Lappin et al 2002, Mouzin et al 2004) antibodies in normal cats, lessening the predictive value of these assays. However, previous studies have shown increased FHV-1 (Lommer and Verstraete 2003) and FCV (Knowles et al 1989, Lommer and Verstraete 2003) carriage rates in cats with GS compared to normal cats by use of viral isolation. In addition, one cat with chronic stomatitis was PCR positive for FHV-1, 14 months after an upper respiratory infection (Hargis and Ginn 1999). These results suggested that detection of FHV-1, FCV, or Bartonella species in the oral cavity may be more predictive than the results of antibody assays.

To our knowledge, the study described here was the first to attempt to correlate presence of microbial DNA or RNA amplified from oral swabs collected from cats with and without GS housed in the same environment. Of the five Bartonella species positive samples, only one came from a cat with GS; FHV-1 and FCV were not amplified from any of the cats with GS. We believe false negative Bartonella species and FHV-1 PCR assays caused by poor sampling were uncommon because DNA was detected by spectrophotometry in all samples. The viral capsid of FCV protects against RNAase degradation and so we also believe false negative FCV RT-PCR assay results were unlikely. However, as mentioned previously, there are a number of factors that may have contributed to these findings.

It is possible that the organisms are not equally distributed through the oral cavity and could have been missed by our sampling technique. It is also possible that organisms were present in deeper tissues of the cats with GS but not the superficial samples collected by oral swab. However, Bartonella species DNA has rarely been detected in tissues of cats with GS in an ongoing prospective study in our laboratory (Dowers and Lappin 2005). It is also possible shipping and storage affected assay results. Another consideration is that chronic GS may be caused by a hypersensitivity reaction against the microbes, leading to clearance of the agents and false negative results in PCR, RT-PCR, or virus isolation. Sampling cats early in the syndrome may be more likely to show an association. Both FCV and FHV-1 have latent phases and so test results may only be positive intermittently (Hargis and Ginn 1999). It is possible that Bartonella species, FHV-1, and FCV are only involved with subsets of cats or GS and future studies of this type should attempt to classify the lesions by severity and location within the mouth. Lastly, different strains of Bartonella species (Mikolajczyk and O'Reilly 2000), FHV-1 (Hargis and Ginn 1999, Hamano et al 2003), and FCV (Geissler et al 1997, Poulet et al 2000, Hurley et al 2004) have different degrees of virulence which may relate to the development of GS.

To our knowledge, this is the first study to compare the results of Bartonella species PCR assay on blood and oral swab samples collected from naturally infected cats. While the cats had all been exposed to fleas previously, the owner had consistently used flea control products for the last 1.5 years and felt the cats had been flea free during that time. Thus, it is likely the Bartonella species infected cats in this study maintained their infections for months, confirming the findings of others using experimentally infected cats (Kordick et al 1999). Bartonella species bacteremia was only documented in one of 45 cats (2.2%), none of the five cats with Bartonella species DNA amplified from oral swabs were currently bacteremic, and only one cat with Bartonella species DNA amplified from an oral swab had stomatitis. The results show that use of blood or oral swab PCR assay results is unlikely to correlate with the presence of GS. In addition, the results also confirm that Bartonella species DNA can be present intermittently in blood and so detection of a single negative PCR assay result cannot be used to accurately assess infection status of cats (Brunt et al 2006). Bartonella henselae lives in flea dirt for 3–9 days after being passed by fleas (Higgins et al 1996, Finkelstein et al 2002) and B henselae or Bartonella clarridgeaie DNA was amplified from 59.7% of fleas collected from naturally exposed cats (Lappin et al 2006b). Thus, amplification of Bartonella species DNA from oral cavity swabs could result from grooming behavior and ingestion of Bartonella species in flea dirt. However, the cats in this study had not been exposed to fleas in the last 1.5 years and so the positive Bartonella species PCR assay results may document the presence of infected red blood cells in the mouth even without gross evidence of GS. These findings support the recommendations that flea control should be maintained at all times and that bites and scratches should be avoided (Brunt et al 2006).

In conclusion, a correlation between the presence of GS and FCV, FHV, FIV, FeLV or Bartonella species in this colony of cases was not identified and so the results did not support disease causation by any of the five agents. Diagnostic test results for these infectious agents should be interpreted carefully as none appear to correlate to the presence or absence of disease.

Footnotes

Acknowledgements

Supported by funding from The Kenneth W. Smith Professorship at Colorado State University.

References

Abbot

R.C.

Chomel

B.B.

Kasten

R.W.

Floyd-Hawkins

K.A.

Kikuchi

Koehler

J.E.

Pedersen

N.C.

Experimental and natural infection with Bartonella henselae in domestic cats, Comparative Immunology Microbiology and Infectious Diseases 20, 1997, 41–51.

Addie

D.D.

Radford

Yam

P.S.

Taylor

D.J.

Cessation of feline calicivirus shedding coincident with resolution of chronic gingivostomatitis in a cat, Journal of Small Animal Practice 44, 2003, 172–176.

Breitschwerdt

E.B.

Levine

J.F.

Radulovic

Hanby

S.B.

Kordick

D.L.

La Perle

K.M.D.

Bartonella henselae and Rickettsia seroreactivity in a sick cat population from North Carolina, International Journal of Applied Research in Veterinary Medicine 3, 2005, 287–302.

Brunt

Guptill

Kordick

D.L.

Kudrak

Lappin

M.R.

American Association of Feline P and Academy of Feline Medicine Advisory P. American Association of Feline Practitioners 2006 Panel report on diagnosis treatment and prevention of Bartonella species infections, Journal of Feline Medicine and Surgery 8, 2006, 213–226.

Burgesser

K.M.

Hotaling

Schiebel

Ashbaugh

S.E.

Roberts

S.M.

Collins

J.K.

Comparison of PCR, virus isolation, and indirect fluorescent antibody staining in the detection of naturally occurring feline herpesvirus infections, Journal of Veterinary Diagnostic Investigation 11, 1999, 122–126.

Chomel

B.B.

Abbott

R.C.

Kasten

R.W.

Floyd-Hawkins

K.A.

Kass

P.H.

Glaser

C.A.

Pedersen

N.C.

Koehler

J.E.

Bartonella henselae prevalence in domestic cats in California: risk factors and association between bacteremia and antibody titers, Journal of Clinical Microbiology 33, 1995, 2445–2450.

Chomel

B.B.

Wey

A.C.

Kasten

R.W.

Stacy

B.A.

Labelle

Fatal case of endocarditis associated with Bartonella henselae type I infection in a domestic cat, Journal of Clinical Microbiology 41, 2003, 5337–5339.

Dowers

K.L.

Lappin

M.R.

The association of Bartonella species infection with chronic stomatitis in cats, Journal of Veterinary Internal Medicine 19, 2005, 471, (abstract)

Fabbi

De Giuli

Tranquillo

Bragoni

Casiraghi

Genchi

Prevalence of Bartonella henselae in Italian stray cats: evaluation of serology to assess the risk of transmission of Bartonella to humans, Journal of Clinical Microbiology 42, 2004, 264–268.

10.

Finkelstein

J.L.

Brown

T.P.

O'Reilly

K.L.

Studies on the growth of Bartonella henselae in the cat flea (Siphonaptera: pulicidae), Journal of Medical Entomology 39, 2002, 915–919.

11.

Geissler

Schneider

Platzer

Truyen

Kaaden

O.R.

Truyen

Genetic and antigenic heterogeneity among feline calicivirus isolates from distinct disease manifestations, Virus Research 48, 1997, 193–206.

12.

Glaus

Hofmann-Lehmann

Greene

Glaus

Wolfensberger

Lutz

Seroprevalence of Bartonella henselae infection and correlation with disease status in cats in Switzerland, Journal of Clinical Microbiology 35, 1997, 2883–2885.

13.

Guptill

Slater

C.C.

Glickman

L.T.

Lin

T.L.

Welch

D.F.

Crippen

J.T.

HogenEsch

Immune response of neonatal specific pathogen-free cats to experimental infection with Bartonella henselae, Veterinary Immunology and Immunopathology 71, 1999, 233–243.

14.

Guptill

Slater

C.C.

Lin

T.L.

Glickman

L.T.

Welch

D.F.

HogenEsch

Experimental infection of young specific pathogen-free cats with Bartonella henselae, Journal of Infectious Diseases 176, 1997, 206–216.

15.

Guptill

Slater

L.N.

C.C.

Lin

T.L.

Glickman

L.T.

Welch

D.F.

Tobolski

HogenEsch

Evidence of reproductive failure and lack of perinatal transmission of Bartonella henselae in experimentally infected cats, Veterinary Immunology and Immunopathology 65, 1998, 177–189.

16.

Guptill

C.C.

HogenEsch

Slater

L.N.

Glickman

Dunham

Syme

Glickman

Prevalence, risk factors, and genetic diversity of Bartonella henselae infections in pet cats in four regions of the United States, Journal of Clinical Microbiology 42, 2004, 652–659.

17.

Hamano

Maeda

Mizukoshi

Une

Mochizuki

Tohya

Akashi

Kai

Experimental infection of recent field isolates of feline herpesvirus type 1, Journal of Veterinary Medical Science 65, 2003, 939–943.

18.

Hargis

A.M.

Ginn

P.E.

Feline herpesvirus 1-associated facial and nasal dermatitis and stomatitis in domestic cats, Veterinary Clinics of North America Small Animal Practice 29, 1999, 1281–1290.

19.

Higgins

J.A.

Radulovic

Jaworski

D.C.

Azad

A.F.

Acquisition of the cat scratch disease agent Bartonella henselae by cat fleas (Siphonaptera: pulicidae), Journal of Medical Entomology 33, 1996, 490–495.

20.

Hurley

K.E.

Pesavento

P.A.

Pedersen

N.C.

Poland

A.M.

Wilson

Foley

J.E.

An outbreak of virulent systemic feline calicivirus disease, Journal of the American Veterinary Medical Association 224, 2004, 241–249.

21.

Jensen

W.A.

Fall

M.Z.

Rooney

Kordick

D.L.

Breitschwerdt

E.B.

Rapid identification and differentiation of Bartonella species using a single-step PCR assay, Journal of Clinical Microbiology 38, 2000, 1717–1722.

22.

Ketring

K.L.

Zuckerman

E.E.

Hardy

W.D.

Jr.

Bartonella: a new etiological agent of feline ocular disease, Journal of the American Animal Hospital Association 40, 2004, 6–12.

23.

Knowles

J.O.

Gaskell

R.M.

Gaskell

C.J.

Harvey

C.E.

Lutz

Prevalence of feline calicivirus, feline leukaemia virus and antibodies to FIV in cats with chronic stomatitis, Veterinary Record 124, 1989, 336–338.

24.

Knowles

J.O.

McArdle

Dawson

Studies on the role of feline calicivirus in chronic stomatitis in cats, Veterinary Microbiology 27, 1991, 205–219.

25.

Kordick

D.L.

Breitschwerdt

E.B.

Relapsing bacteremia after blood transmission of Bartonella henselae to cats, American Journal of Veterinary Research 58, 1997, 492–497.

26.

Kordick

D.L.

Brown

T.T.

Shin

Breitschwerdt

E.B.

Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats, Journal of Clinical Microbiology 37, 1999, 1536–1547.

27.

Lappin

M.R.

Andrews

Simpson

Jensen

W.A.

Use of serologic tests to predict resistance to feline herpesvirus 1, feline calicivirus, and feline parvovirus infection in cats, Journal of the American Veterinary Medical Association 220, 2002, 38–42.

28.

Lappin

M.R.

Black

J.C.

Bartonella spp infection as a possible cause of uveitis in a cat, Journal of the American Veterinary Medical Association 214, 1999, 1205–1207, 1200.

29.

Lappin

M.R.

Hawley

J.R.

Breitschwerdt

E.B.

Bartonella spp. antigen recognition patterns in cats with and without fever, Journal of Veterinary Internal Medicine 20, 2006a, 710.

30.

Lappin

M.R.

Griffin

Brunt

Riley

Burney

Hawley

Brewer

M.M.

Jensen

W.A.

Prevalence of Bartonella species, Mycoplasma species, Ehrlichia species, and Anaplasma phagocytophilum DNA in the blood of cats and their fleas in the United States, Journal of Feline Medicine and Surgery 8, 2006b, 85–90.

31.

Lappin

M.R.

Kordick

D.L.

Breitschwerdt

E.B.

Bartonella spp antibodies and DNA in aqueous humour of cats, Journal of Feline Medicine and Surgery 2, 2000, 61–68.

32.

Lommer

M.J.

Verstraete

F.J.

Concurrent oral shedding of feline calicivirus and feline herpesvirus 1 in cats with chronic gingivostomatitis, Oral Microbiology and Immunology 18, 2003, 131–134.

33.

Lyon

K.F.

Gingivostomatitis, Veterinary Clinics of North America Small Animal Practice 35, 2005, 891–911, [vii]

34.

Maggs

D.J.

Lappin

M.R.

Reif

J.S.

Collins

J.K.

Carman

Dawson

D.A.

Bruns

Evaluation of serologic and viral detection methods for diagnosing feline herpesvirus-1 infection in cats with acute respiratory tract or chronic ocular disease, Journal of the American Veterinary Medical Association 214, 1999, 502–507.

35.

Mikolajczyk

M.G.

O'Reilly

K.L.

Clinical disease in kittens inoculated with a pathogenic strain of Bartonella henselae, American Journal of Veterinary Research 61, 2000, 375–379.

36.

Mouzin

D.E.

Lorenzen

M.J.

Haworth

J.D.

King

V.L.

Duration of serologic response to three viral antigens in cats, Journal of the American Veterinary Medical Association 224, 2004, 61–66.

37.

O'Reilly

K.L.

Bauer

R.W.

Freeland

R.L.

Foil

L.D.

Hughes

K.J.

Rohde

K.R.

Roy

A.F.

Stout

R.W.

Triche

P.C.

Acute clinical disease in cats following infection with a pathogenic strain of Bartonella henselae (LSU16), Infection and Immunity 67, 1999, 3066–3072.

38.

Pearce

Radecki

Brewer

Lappin

M.R.

Prevalence of Bartonella henselae specific antibodies in serum of cats with and without clinical signs of central nervous system disease, Journal of Feline Medicine and Surgery 8, 2006, 315–320.

39.

Poulet

Brunet

Soulier

Comparison between acute oral/respiratory and chronic stomatitis/gingivitis isolates of feline calicivirus: pathogenicity, antigenic profile and cross-neutralization studies, Archives of Virology 145, 2000, 243–261.

40.

Powell

C.C.

Kordick

D.L.

Lappin

M.R.

Inoculation with Bartonella henselae followed by feline herpesvirus 1 fails to activate ocular toxoplasmosis in chronically infected cats, Journal of Feline Medicine and Surgery 4, 2002, 107–110.

41.

Regnery

R.L.

Rooney

J.A.

Johnson

A.M.

Nesby

S.L.

Manzewitsch

Beaver

Olson

J.G.

Experimentally induced Bartonella henselae infections followed by challenge exposure and antimicrobial therapy in cats, American Journal of Veterinary Research 57, 1996, 1714–1719.

42.

Sykes

J.E.

Studdert

V.P.

Browning

G.F.

Detection and strain differentiation of feline calicivirus in conjunctival swabs by RT-PCR of the hypervariable region of the capsid protein gene, Archives of Virology 143, 1998, 1321–1334.

43.

Tenorio

A.P.

Franti

C.E.

Madewell

B.R.

Pedersen

N.C.

Chronic oral infections of cats and their relationship to persistent oral carriage of feline calici-, immunodeficiency, or leukemia viruses, Veterinary Immunology and Immunopathology 29, 1991, 1–14.

44.

Ueno

Hohdatsu

Muramatsu

Koyama

Morita

Does coinfection of Bartonella henselae and FIV induce clinical disorders in cats?, Microbiology and Immunology 40, 1996, 617–620.

45.

Waters

Hopper

C.D.

Gruffydd-Jones

T.J.

Harbour

D.A.

Chronic gingivitis in a colony of cats infected with feline immunodeficiency virus and feline calicivirus, Veterinary Record 132, 1993, 340–342.

46.

Yamamoto

Chomel

B.B.

Kasten

R.W.

Hew

C.M.

Weber

D.K.

Lee

W.I.

Experimental infection of specific pathogen free (SPF) cats with two different strains of Bartonella henselae type I: a comparative study, Veterinary Research 33, 2002a, 669–684.

47.

Yamamoto

Chomel

B.B.

Kasten

R.W.

Hew

C.M.

Weber

D.K.

Lee

W.I.

Droz

Koehler

J.E.

Experimental infection of domestic cats with Bartonella koehlerae and comparison of protein and DNA profiles with those of other Bartonella species infecting felines, Journal of Clinical Microbiology 40, 2002b, 466–474.

48.

Yamamoto

Chomel

B.B.

Kasten

R.W.

Hew

C.M.

Weber

D.K.

Lee

W.I.

Koehler

J.E.

Pedersen

N.C.

Infection and re-infection of domestic cats with various Bartonella species or types: B. henselae type I is protective against heterologous challenge with B. henselae type II, Veterinary Microbiology 92, 2003, 73–86.